22-hydroxycholesterol has been researched along with Ischemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernabeu, C; Blanco, FJ; Castrillo, A; Díaz, M; Gonzalez-Nuñez, M; Langa, C; Llano, E; Lopez-Novoa, JM; Oujo, B; Pendas, AM; Valbuena-Diez, AC | 1 |
1 other study(ies) available for 22-hydroxycholesterol and Ischemia
Article | Year |
---|---|
Oxysterol-induced soluble endoglin release and its involvement in hypertension.
Topics: Animals; Anticholesteremic Agents; Antigens, CD; Blood Pressure; Cell Line, Tumor; Choriocarcinoma; Endoglin; Female; Human Umbilical Vein Endothelial Cells; Humans; Hydrocarbons, Fluorinated; Hydroxycholesterols; Intracellular Signaling Peptides and Proteins; Ischemia; Liver X Receptors; Male; Matrix Metalloproteinase 14; Mice; Mice, Inbred C57BL; Mice, Transgenic; Orphan Nuclear Receptors; Placenta Diseases; Pre-Eclampsia; Pregnancy; Receptors, Cell Surface; Sulfonamides; Tissue Inhibitor of Metalloproteinase-3; Uterine Neoplasms | 2012 |